Breast Cancer and Oral Contraception
By Ruben Obregon
October is Breast Cancer Awareness
month, which is an annual campaign to
build public awareness about the disease
as well as to raise funds for research.
What does this educational campaign
have to do with contraception? It has to
do with the fact that many types of oral
contraceptives contain synthetic estrogen, a
steroid believed to have a
role in the development of breast
cancer.[1]
Over the past two decades, multiple
analyses and studies have provided
convincing evidence that using oral
contraceptives increases the risk of
breast cancer. (See "For Further
Reading" below.) The
evidence keeps mounting -- separate
studies published in the January 2006
edition of the New England
Journal of Medicine,[2] the
October 2006 edition of Cancer
Epidemiology Biomarkers & Prevention,[3]
and the October 2006 edition of Mayo
Clinic Proceedings [4] confirm the
increased risk.
The evidence puts contraception
advocates in an awkward position of
having to admit that the pill isn’t as
safe as it presumed to be. Yet they
cannot ignore the published evidence and
maintain credibility, so they simply
minimize the cancer risk by making it
sound insignificant. Additionally, these advocates try to “balance”
out the risk by
emphasizing the fact that the pill can
reduce the risk of developing endometrial and
ovarian cancer.
Oral contraceptives not only pose a
risk for breast cancer, but for liver
and cervical cancer as well.[5]
Considering the associated cancer risks,
one has to wonder if it really is a good
idea to "treat" the healthy state of
fertility with know carcinogens.
“Family planning” organizations are
not the only ones that find themselves in an awkward
position concerning oral contraception.
The Susan G. Komen Breast Cancer
Foundation, the sponsor of the “Race for
the Cure©”, has given hundreds of
thousands of dollars to Planned
Parenthood. Planned Parenthood
routinely distributes these carcinogenic
drugs to millions of women and teenage
girls, something which appears to
conflict with the foundation's efforts
to eradicate breast cancer.
Many in the medical community are
also involved in the effort to
neutralize the cancer risk oral
contraceptives pose. Many physicians
downplay the seriousness of
contraception related breast cancer,
typically citing the tendency for the
cancer to not spread beyond the breast.
Even though the treatment of localized breast cancer is
highly successful, it’s not
entirely curable.
The five year survival rate for
localized breast cancer is 98.5% for
white women and 92.2% for African
American women.[6] Though
typically confined to the breasts,
the cancer can still spread,
significantly reducing the survival
rates.
Oral contraceptives are not the only
form of birth control that increases the
risk of breast cancer. The World Health
Organization found that Depo-Provera, an
injectable contraception (which also
acts as an abortifacient), also poses a
breast cancer risk for users under 35.
[7]
Oral contraceptives are the leading
choice of contraception for women under
35, meaning that millions of women are
increasing their risk of developing
breast cancer. A 2003 study of young
breast cancer patients revealed that
oral contraception was a significant
factor in breast cancer patients aged
20-35 [8] The study also revealed that
the highest risk for OC use was five
years prior to diagnosis.[9]
In 2002 alone, over 1.6 million women
between the ages of 15-19 were using
oral contraceptives [10] putting
themselves at greater risk for
developing cancer in their early to mid
twenties.
Many of these young women are taking
oral contraceptives without their
parent's knowledge or consent, and at
the taxpayer's expense via the Title X
program. Title X is a Federal program
which gives funds to “family planning”
programs across the nation. Programs
which receive Title X funding distribute
these carcinogenic drugs to a large
number of underage girls, and in most
states, without parental consent.
Some would say that the cancer risk is
minor, or that an insignificant amount
of women will develop breast cancer as a
result of using oral contraception. No
case of breast cancer is insignificant,
and one death from contraception related
breast cancer is one death too many.
Breast cancer treatment isn’t a minor
event either – it often involves removal
of all or part of the breast, radiation
if part of the breast is removed, and if
the tumor is invasive, chemotherapy.
This doesn’t sound the least bit
insignificant, except to those who care
more about “reproductive rights” than
women’s health.
October is Breast Cancer Awareness
month, a perfect time to raise awareness
of the link between oral contraception
and breast cancer. An excellent way to
help spread the word is to email friends
and family a link to this excellent
publication on breast cancer and
contraception, published by the Breast
Cancer Prevention Institute:
If it's not OK for him to take
steroids...Why is it OK for her?
To receive No Room for
Contraception updates and articles via
e-mail, click [here]

------------
Enjoyed this article? Read
"Birth Control Is Selfish" ... The
Message Society Doesn't Want To Hear
------------
For Further Reading: Analyses and Studies
2006 -- Meta analysis confirms
increased risk for breast cancer in
pre-menopausal users, especially for
before first full term pregnancy (FFTP)
users. click [here]
(PDF - Acrobat reader required)
Text abstract available [here]
2006 -- Study published in
October 2006 confirms elevated risk with
oral contraceptive use (but finds no
increased risk with use by BRCA1 and
BRCA2 mutation carriers). click [here]
2006 -- Article in the New
England Journal of Medicine reaffirms
the oral contraceptive breast cancer
link. click [here]
2005 -- WHO IARC declares
combined oral estrogen-progestogen
contraceptives "carcinogenic to humans"
-- implicated in breast, cervix, and
liver cancer. click [here]
2003 -- National Cancer
Institute Sponsored study indicates
increased risk of breast cancer for
women aged 20-34 who used oral
contraceptives prior to diagnosis.
click [here]
2002 -- 3rd European Breast
Cancer Conference presented with
evidence of increased risk of breast
cancer by users of oral contraceptives.
click [here]
2002 -- Case control study
published in the new England Journal of
Medicine showed no excess risk for oral
contraceptive use in women over 35.
click [here]
1996 --An analysis of studies
from around the world shows that women
who used contraception in the past five
years had an increased risk of breast
cancer. click [here]
1980 --An analysis of 21 studies
showed an increase risk in using the
pill. click [here]
Footnotes
[1] Love, S, Dr. Susan Love's
Breast Book, 2006, page 192
[2] Yager, J, Davidson, N, Estrogen
Carcinogenesis in Breast Cancer, The
New England Journal of Medicine,
2006;354:270-82. Available from
http://content.nejm.org/cgi/content/extract/354/3/270?ck=nck
(subscription required).
[3] Haile, R, Thomas, D, McGuire,V,
Felberg, A, John E, Milne, R, Hopper, J,
Jenkins, M, Levine, A, Daly, M, Buys, S,
Senie, R, Andrulis, I, Knight, J,
Godwin, A, Southey, M, McCredie, M,
Giles, G, Andrews, L, Tucker, K, Miron,
A, Apicella, C, Tesoriero, A, Bane, A,
Pike, M, Whittemore, A, ConFab
Investigators Ontario Cancer Genetics
Network Investigators, BRCA1 and
BRCA2 Mutation Carriers, Oral
Contraceptive Use, and Breast Cancer
Before Age 50, Cancer Epidemiology
Biomarkers & Prevention Vol. 15,
1863-1870, October 2006. Available
from:
http://cebp.aacrjournals.org/cgi/content/short/15/10/1863?rss=1
[4] Kahlenborn, C, Modugno, F, Potter,
D, Severs, W, Oral Contraceptive Use
as a Risk Factor for Premenopausal
Breast Cancer: A Meta-analysis, The
Mayo Clinic Proceedings, October
2006;81(10):1290-1302. Available
at
http://www.mayoclinicproceedings.com/pdf/8110/8110a1.pdf
(Subscription required, pdf - Adobe
Acrobat required..) Text abstract
available at
http://www.mayoclinicproceedings.com/Abstract.asp?AID=4166&UID=38064&Abst=Abstract
[5] World Health Organization, Iarc
Monographs Programme Finds Combined
Estrogen-Progestogen Contraceptives And
Menopausal Therapy Are Carcinogenic To
Humans,
World Health Organization Press Release
N° 167, 29 July 2005, Available from
http://www.iarc.fr/ENG/Press_Releases/pr167a.html
[6] American Cancer Society, Breast
Cancer Facts & Figures 2005-2006.
Atlanta: American Cancer Society, Inc.,
which cites Surveillance, Epidemiology,
and End Results Program, 1973-2002,
Division of Cancer Control and
Population Sciences, National Cancer
Institute, 2005.
[7] Pharmacia, Depo-Provera
Contraceptive Injection – Physician
Information, no author listed.
Available from
http://www.pfizer.com/pfizer/download/uspi_depo_provera_contraceptive.pdf
(Adobe PDF required)
[8] Althuis MD, Brogan DD, Coates RJ,
Daling JR, Gammon MD, Malone KE,
Schoenberg JB, Brinton LA., Breast
cancers among very young premenopausal
women. Available from
http://www.springerlink.com/content/v328t6742723782w/
(purchase required)
[9] Ibid.
[10] Fertility, Family Planning, and
Reproductive Health of U.S.
Women: Data From the 2002 National
Survey of Family Growth, Vital
Statistics, U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES Centers for
Disease Control and Prevention, Series
23, No. 25 [ Page 95], Table 56. Number
of women 15–44 years of age and percent
distribution by current contraceptive
status and method, according to age at
interview: United States, 2002.
ABOUT THE AUTHOR
Ruben Obregon is the the President and
co-founder of No Room for Contraception.
He has worked in the pro-family movement
for the past 16 years on issues ranging
from education to marriage.